Delivery Order SPE2DB22D2218-SPE2DB25FR1TP
Award Date
12/9/24
Potential Completion Date
12/10/24
Potential Value
$17K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,591.16, was awarded to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The award does not have a set-aside designation and has an ultimate completion date of August 9, 2024.
Amerisourcebergen has been awarded numerous federal...
This federal contract award is for the delivery of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML medical devices to the Defense Logistics Agency (DLA). The $4,457.54 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on January 12, 2024. The order has an ultimate completion date of January 16, 2024 and is not designated as a set-aside contract.
Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
This federal contract award is for the delivery of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,567.55, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation, and is a firm fixed price delivery order. The award is not associated with any set-aside designation.
Amerisourcebergen Drug Corp holds an Indefinite Delivery...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to Amerisourcebergen Drug Corporation's Corporate Office Division, a major pharmaceutical distributor, to provide GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML medical products. The contract has a ceiling value of $9,718.13 and a performance period through June 17, 2024. Amerisourcebergen also holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,601.00 firm fixed-price delivery order is for the supply of GVOKE HYPOPEN 2PK 0.5MG/0.1 ML 0.1ML, a medication used in the treatment of various medical conditions. The contract has an ultimate completion date of November 8, 2024 and was awarded on November 7, 2024. AmerisourceBergen is a for-profit...
This federal contract award is for the delivery of GVOKE HYPOPEN 1-PK 1 MG/0.2 ML 0.2ML pharmaceutical products to the Defense Logistics Agency (DLA). The $2,850.03 firm fixed price delivery order was awarded to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation.
Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, is a for-profit organization that serves as a prime contractor providing a...
This federal contract award is for the delivery of GVOKE HYPOPEN 1-PK 1 MG/0.2 ML 0.2ML medical devices. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense. The contract has a ceiling value of $1,201.74 and runs through November 12, 2024. It is a firm fixed-price delivery order contract with no set-aside requirements,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The contract, with a ceiling value of $7,375.29, is for the delivery of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp, a major pharmaceutical distributor in the U.S., has...
This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML medication. The firm-fixed-price delivery order has a total ceiling value of $1,305.18 and an ultimate completion date of July 24, 2024. This award is not associated with any set-aside program. AmerisourceBergen is the prime contractor for this contract, which supports the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,565.92 firm fixed-price delivery order is for the supply of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML medical devices. The contract has an ultimate completion date of October 22, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...